Dr. Kaveh Hoda

Wow, I'm just impressed that the orthopedic surgeons were reading anything. Hey-o! Sorry. Sorry, that's my little dig at the orthopedic surgeons.

Wow, I'm just impressed that the orthopedic surgeons were reading anything. Hey-o! Sorry. Sorry, that's my little dig at the orthopedic surgeons.

Wow, I'm just impressed that the orthopedic surgeons were reading anything. Hey-o! Sorry. Sorry, that's my little dig at the orthopedic surgeons.

Did he say that himself? He called his own studies meticulous? No, no.

Did he say that himself? He called his own studies meticulous? No, no.

Did he say that himself? He called his own studies meticulous? No, no.

You know, it's like the it's what's interesting to me is looking at these things is what could the FDA have done better in some of these circumstances? It's hard because some of the information just not being given to them in what seems like a very fraudulent manner. But they need to have the power to do certain things.

You know, it's like the it's what's interesting to me is looking at these things is what could the FDA have done better in some of these circumstances? It's hard because some of the information just not being given to them in what seems like a very fraudulent manner. But they need to have the power to do certain things.

You know, it's like the it's what's interesting to me is looking at these things is what could the FDA have done better in some of these circumstances? It's hard because some of the information just not being given to them in what seems like a very fraudulent manner. But they need to have the power to do certain things.

When a drug is first approved, there's still a lot of unanswered early safety questions. Because for most of the studies that are getting them approved... There's like maybe 2,000 to 4,000 at most patients in a study. Oftentimes, that's not enough to see the safety evidence and what risks are associated with it.

When a drug is first approved, there's still a lot of unanswered early safety questions. Because for most of the studies that are getting them approved... There's like maybe 2,000 to 4,000 at most patients in a study. Oftentimes, that's not enough to see the safety evidence and what risks are associated with it.

When a drug is first approved, there's still a lot of unanswered early safety questions. Because for most of the studies that are getting them approved... There's like maybe 2,000 to 4,000 at most patients in a study. Oftentimes, that's not enough to see the safety evidence and what risks are associated with it.

So the FDA has to be there pushing to see more data, making sure that it stays safe once those numbers come out. They need to be there to do the post-marketing studies. It's interesting to me to see, it's terrifying to me to see, going back to what's coming in the future, what's going to happen to our FDA. Oh, God.

So the FDA has to be there pushing to see more data, making sure that it stays safe once those numbers come out. They need to be there to do the post-marketing studies. It's interesting to me to see, it's terrifying to me to see, going back to what's coming in the future, what's going to happen to our FDA. Oh, God.

So the FDA has to be there pushing to see more data, making sure that it stays safe once those numbers come out. They need to be there to do the post-marketing studies. It's interesting to me to see, it's terrifying to me to see, going back to what's coming in the future, what's going to happen to our FDA. Oh, God.

and how deregulated it's going to become and to see what they're going to be able to accomplish. It's going to be, I mean, I hate to say it, but I think we're going to see more drug-induced injuries than ever before because more medicines are going to be coming out and fewer of them are going to have the post-marketing studies to prove it.

and how deregulated it's going to become and to see what they're going to be able to accomplish. It's going to be, I mean, I hate to say it, but I think we're going to see more drug-induced injuries than ever before because more medicines are going to be coming out and fewer of them are going to have the post-marketing studies to prove it.

and how deregulated it's going to become and to see what they're going to be able to accomplish. It's going to be, I mean, I hate to say it, but I think we're going to see more drug-induced injuries than ever before because more medicines are going to be coming out and fewer of them are going to have the post-marketing studies to prove it.

I'm like, you know, I get a lot of shit online for being like a pharma shill. Yeah. Because like, you know, I promote vaccines like because they work and they're great. And, you know, I can go into that in great detail if you like. But like the...

I'm like, you know, I get a lot of shit online for being like a pharma shill. Yeah. Because like, you know, I promote vaccines like because they work and they're great. And, you know, I can go into that in great detail if you like. But like the...